Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Critical Care Medicine · Hypercatabolic State

Managing the Protein 'Burn'

At a Glance

Hypercatabolic states can make the body break down albumin, IgG, and muscle faster than they are replaced. Recovery depends on treating the underlying illness, providing individualized protein and calories, preventing infections when IgG is low, and rebuilding strength over time.

Managing a hypercatabolic state is not as simple as “replacing what is lost.” Because your body is actively destroying proteins like albumin and IgG, the focus must shift from temporary fixes to addressing the underlying drivers and supporting your body’s specialized nutritional needs [1][2].

The Challenge of Albumin Infusions

It is a common misconception that if albumin is low, the routine solution is to infuse more. In hypercatabolic states, however, albumin infusions are often ineffective for long-term management of chronic low protein [3][4].

  • The “Short Half-Life” Problem: In a healthy person, albumin lasts for about 20 days. In a hypercatabolic person, the body may break it down in just a few days or leak it into the surrounding tissues due to inflammation [2][5].
  • A “Band-Aid,” Not a Cure: While infusions are appropriate and necessary for specific indications (such as managing certain complications of cirrhosis, large-volume paracentesis, or carefully selected volume-management situations), they do not fix the underlying reason why the protein is disappearing. Using them just to “fix the number” on a lab report has not been shown to improve survival or reduce infections in most patients [4][6].
  • The Risks: Too much infused albumin can lead to fluid overload, which may cause swelling in the lungs (pulmonary edema) or strain the heart [7][8].

Nutritional Support: Achieving Nitrogen Balance

The goal of treatment is to reach nitrogen balance—a state where the amount of protein you take in matches or exceeds the amount your body is breaking down [9][10].

  • Protein Targets: Most critically ill patients in a hypercatabolic state require significantly more protein than a healthy person. Doctors often target between 1.2 and 2.0 grams of protein per kilogram of body weight daily as an example, but this must be individualized based on your kidney and liver function, phase of illness, and fluid status. Do not self-prescribe protein supplements [11][12].
  • The “Fuel” Requirement: Protein alone isn’t enough. If you don’t consume enough calories (energy), your body will simply burn the extra protein for fuel instead of using it to build muscle [1][13].
  • Monitoring Success: Doctors may track your progress using specialized tests or bedside muscle ultrasounds to see if you are maintaining your lean body mass (muscle) [14][9].

Managing the Two Types of Hypercatabolism

Your treatment path depends heavily on whether your condition is “acquired” or genetic (FIHH).

1. Addressing the Underlying Drivers (Acquired)

If your condition is caused by an illness like sepsis, cancer, or major trauma, the protein breakdown will not stop until the underlying inflammation is controlled [1]. Treatment involves:

  • Aggressively treating infections or the primary disease [1].
  • Using medications or therapies to address the body’s inflammatory response, safely tailored to the specific cause [15].
  • Early physical therapy (mobilization) when clinically stable to signal the body to keep and use its muscle tissue [16].

2. Protecting the Immune System (Genetic / FIHH)

In the rare genetic form where the body fails to recycle IgG (antibodies), the biggest risk is infection [17].

  • Immunoglobulin Replacement (IVIG/SCIG): If your IgG levels are dangerously low, an immunologist will review your history of recurrent or serious documented infections, functional antibody responses, and secondary causes. They may infuse “donor” antibodies. This is usually done every 1 to 4 weeks based on individual need [18][19].
  • Infection Prevention: This includes staying up to date on vaccinations (consult your doctor before receiving live vaccines) and, in some cases, taking daily “prophylactic” antibiotics to prevent infections before they start [20][21].

A Note on Recovery

Recovery from a hypercatabolic state is a marathon, not a sprint. Even after the initial illness is gone, it can take months of dedicated nutritional support and rehabilitation to restore the protein and muscle mass your body consumed during the crisis [16]. Working closely with a clinical dietitian is essential to adjust your “protein prescription” safely as you heal [16].

Common questions in this guide

What is the nutrition goal during a hypercatabolic state?
The goal is nitrogen balance, meaning the protein you consume matches or exceeds the protein your body breaks down. Calories are also important because without enough energy, the body may burn protein for fuel instead of using it to maintain muscle.
Can an albumin infusion permanently correct low albumin?
Usually not when ongoing inflammation or hypercatabolism is causing the protein loss. Albumin may be appropriate for specific medical indications, but repeated infusions can cause fluid overload and should be guided by your healthcare team.
How much protein should I eat when my body is breaking down protein?
Critically ill people may need about 1.2 to 2.0 grams of protein per kilogram of body weight each day, but the right amount depends on kidney and liver function, the stage of illness, and fluid status. Do not start high-protein supplements without guidance from your healthcare team or clinical dietitian.
What causes acquired hypercatabolism, and how is it treated?
Acquired hypercatabolism can occur with severe infection such as sepsis, cancer, major trauma, or other intense inflammation. Treatment focuses on controlling the underlying illness, addressing inflammation when appropriate, and starting physical therapy or mobilization once it is safe.
When might IVIG or SCIG be needed for the genetic form of hypercatabolism?
For the genetic form called FIHH, an immunologist may consider immunoglobulin replacement when IgG is dangerously low and there is a pattern of serious or recurrent infections, after reviewing antibody function and other causes. Treatment schedules vary, often from every one to four weeks.
How can I tell whether treatment is helping me regain protein and muscle?
Your care team may follow protein and antibody levels, dietary intake, infection history, and changes in lean body mass or muscle strength. Recovery can take months, so monitoring and rehabilitation are adjusted as your illness and nutrition needs change.

Get notified when new evidence is published on hypoproteinemia, hypercatabolic.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (21)
  1. 1

    Amino Acids as Metabokines in Hypercatabolic States: Rethinking Nutritional Protein-Based Strategies Beyond Caloric Support.

    Corsetti G, Pasini E

    Nutrients 2026; (18(11)) doi:10.3390/nu18111703.

    PMID: 42280346
  2. 2

    Hypoalbuminemia: Pathogenesis and Clinical Significance.

    Soeters PB, Wolfe RR, Shenkin A

    JPEN. Journal of parenteral and enteral nutrition 2019; (43(2)):181-193 doi:10.1002/jpen.1451.

    PMID: 30288759
  3. 3

    The Use of Visceral Proteins as Nutrition Markers: An ASPEN Position Paper.

    Evans DC, Corkins MR, Malone A, et al.

    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2021; (36(1)):22-28 doi:10.1002/ncp.10588.

    PMID: 33125793
  4. 4

    Albumin: a comprehensive review and practical guideline for clinical use.

    Abedi F, Zarei B, Elyasi S

    European journal of clinical pharmacology 2024; (80(8)):1151-1169 doi:10.1007/s00228-024-03664-y.

    PMID: 38607390
  5. 5

    Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements.

    Levitt DG, Levitt MD

    International journal of general medicine 2016; (9()):229-55 doi:10.2147/IJGM.S102819.

    PMID: 27486341
  6. 6

    Hypoalbuminemia and Clinical Outcomes: What is the Mechanism behind the Relationship?

    Kim S, McClave SA, Martindale RG, et al.

    The American surgeon 2017; (83(11)):1220-1227 doi:10.1177/000313481708301123.

    PMID: 29183523
  7. 7

    Controversies Surrounding Albumin Use in Sepsis: Lessons from Cirrhosis.

    Wiedermann CJ

    International journal of molecular sciences 2023; (24(24)) doi:10.3390/ijms242417606.

    PMID: 38139434
  8. 8

    Systemic capillary leak syndrome: a nosological entity that the nephrologist must be aware of.

    Basile C

    Journal of nephrology 2025; (38(6)):1533-1540 doi:10.1007/s40620-025-02250-4.

    PMID: 40056270
  9. 9

    Estimating Catabolism: A Possible Tool for Nutritional Monitoring of Patients With Acute Kidney Injury.

    Bufarah MN, de Góes CR, Cassani de Oliveira M, et al.

    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2017; (27(1)):1-7 doi:10.1053/j.jrn.2016.09.002.

    PMID: 27810170
  10. 10

    Effect of Protein-Fortified Diet on Nitrogen Balance in Critically Ill Patients: Results from the OPINiB Trial.

    Danielis M, Lorenzoni G, Azzolina D, et al.

    Nutrients 2019; (11(5)) doi:10.3390/nu11050972.

    PMID: 31035354
  11. 11

    Protein nutritional support in critically ill patients: pathophysiological basis, clinical evidence, and areas of uncertainty - a narrative review.

    Qinyuan D, Congcong Q, Guochen L, et al.

    Frontiers in medicine 2026; (13()):1770345 doi:10.3389/fmed.2026.1770345.

    PMID: 42040590
  12. 12

    High protein provision of more than 1.2 g/kg improves muscle mass preservation and mortality in ICU patients: A systematic review and meta-analyses.

    van Ruijven IM, Abma J, Brunsveld-Reinders AH, et al.

    Clinical nutrition (Edinburgh, Scotland) 2023; (42(12)):2395-2403 doi:10.1016/j.clnu.2023.09.026.

    PMID: 37862825
  13. 13

    Prospective Study on Energy Expenditure in Patients With Severe Burns.

    Guo F, Zhou H, Wu J, et al.

    JPEN. Journal of parenteral and enteral nutrition 2021; (45(1)):146-151 doi:10.1002/jpen.1819.

    PMID: 32270887
  14. 14

    Current insights in ICU nutrition: tailored nutrition.

    Hermans AJH, Laarhuis BI, Kouw IWK, van Zanten ARH

    Current opinion in critical care 2023; (29(2)):101-107 doi:10.1097/MCC.0000000000001016.

    PMID: 36762671
  15. 15

    [The Nutrition Care of Severe Burn Patients].

    Hsieh YH

    Hu li za zhi The journal of nursing 2016; (63(1)):22-9.

    PMID: 26813059
  16. 16

    Nutrition recovery after critical illness: toward a personalized, multimodal approach.

    Dupuis C, Preiser JC

    Current opinion in clinical nutrition and metabolic care 2026; (29(3)):253-262 doi:10.1097/MCO.0000000000001197.

    PMID: 41461014
  17. 17

    Two-Pore Minimum Physiologically-based Pharmacokinetic Model to Describe the Disposition of Therapeutic Monoclonal IgG Antibody in Humans.

    Hardiansyah D, Ng CM

    Pharmaceutical research 2018; (35(3)):47 doi:10.1007/s11095-017-2292-2.

    PMID: 29411151
  18. 18

    A Systematic Review and Meta-regression Analysis on the Impact of Increasing IgG Trough Level on Infection Rates in Primary Immunodeficiency Patients on Intravenous IgG Therapy.

    Lee JL, Mohamed Shah N, Makmor-Bakry M, et al.

    Journal of clinical immunology 2020; (40(5)):682-698 doi:10.1007/s10875-020-00788-5.

    PMID: 32417999
  19. 19

    Immunoglobulin therapy for immunodeficiency.

    Wilson BE, Freeman CM

    Allergy and asthma proceedings 2024; (45(5)):364-370 doi:10.2500/aap.2024.45.240053.

    PMID: 39294913
  20. 20

    Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis.

    Chai KL, Wong J, Weinkove R, et al.

    Blood advances 2023; (7(1)):20-31 doi:10.1182/bloodadvances.2022008073.

    PMID: 35882473
  21. 21

    Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy.

    McQuilten ZK, Weinkove R, Thao LTP, et al.

    Blood advances 2024; (8(7)):1787-1795 doi:10.1182/bloodadvances.2023011231.

    PMID: 38592710

This page is for informational purposes only and does not constitute medical advice. Protein, albumin, immunoglobulin, and nutrition decisions should be made with your healthcare team and clinical dietitian.